Is Cosmos Health, Inc. technically bullish or bearish?
2025-09-20 19:54:28As of 11 September 2025, the technical trend for Cosmos Health, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, indicating positive momentum. However, the weekly RSI is bearish, suggesting some short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly and bullish on the monthly, reinforcing the upward trend. The KST is bullish weekly and mildly bullish monthly, while the OBV is bullish monthly, indicating accumulation. In terms of performance, Cosmos Health has outperformed the S&P 500 over the past week and month, with returns of 10.95% and 9.88% respectively, compared to 1.05% and 2.33% for the index. However, the longer-term returns (1Y, 3Y, 5Y, and 10Y) are significantly negative compared to the S&P 500, indicating a challenging historical performance. Overall, t...
Read MoreIs Cosmos Health, Inc. overvalued or undervalued?
2025-09-20 18:28:36As of 18 May 2016, the valuation grade for Cosmos Health, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of 0.54, an EV to EBIT of -1.87, and an EV to EBITDA of -2.06. In comparison, TFF Pharmaceuticals, Inc. has a less negative EV to EBITDA of 0.1173, suggesting that Cosmos is struggling relative to its peers. The company's recent stock performance shows a 39.30% return year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over longer horizons, such as the 3-year and 5-year returns of -89.93% and -98.82%, respectively, indicate severe underperformance compared to the S&P 500's gains. Overall, Cosmos Health, Inc. is deemed overvalued based on its financial metrics and peer comparisons....
Read More





